AstraZeneca (AZN), Merck (MRK) Confirm LYNPARZA Received Additional and Broad Approval in U.S. for Ovarian Cancer
Tweet Send to a Friend
AstraZeneca (NYSE: AZN) and Merck & Co., Inc. (NYSE: MRK), known as MSD outside the United States and Canada, today ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
